United Kingdom · Question · Written question
UIN 6415
Moderna
Original
Introduced
4 October 2024
Last action
14 October 2024 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
14 October 2024
Summary
To ask the Secretary of State for Health and Social Care, what progress he has made with Moderna on the (a) manufacture of mRNA vaccines in the UK, (b) establishment of a global clinical trials base and (c) investment in UK-based research and development
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
4 October 2024
Written question
To ask the Secretary of State for Health and Social Care, what progress he has made with Moderna on the (a) manufacture of mRNA vaccines in the UK, (b) establishment of a global clinical trials base and (c) investment in UK-based research and development
Source: Commons
14 October 2024
Answer
As part of the Moderna-UK Strategic Partnership signed in December 2022, Moderna is building an mRNA vaccine manufacturing facility in Harwell, Oxfordshire. The Moderna Innovation and Technology Centre will support the United Kingdom to be more resilient ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2024-10-04/6415
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1730486
- uk · wq-1730486 · source updated 14 October 2024